Promega Corporation

AKT2 Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant full-length human AKT2 was expressed by baculovirus in Sf9 cells using an N-terminal GST tag. AKT2 or Protein Kinase B β (PKBβ) is a serine/threonine kinase that is a member of the AKT family. AKT2 like the other AKT members is activated in cells in response to diverse stimuli such as hormones, growth factors and extracellular matrix components and is involved in glucose metabolism, transcription, survival, cell proliferation, angiogenesis and cell motility. The PI3K generates phosphatidylinositol-3,4,5-trisphosphate (PIP3), a lipid second messenger essential for th...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for customers of Promega UK Ltd only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

AKT2 Kinase Enzyme System

Close Window

AKT2 Kinase Enzyme System

 Components

10μg
- V3861 £ 261.00 Add to cart

AKT2 Kinase Enzyme System

Close Window

AKT2 Kinase Enzyme System

 Components

1mg
- V3862 Please Enquire

ADP-Glo™ Kinase Assay + AKT2 Kinase Enzyme System

Close Window

ADP-Glo™ Kinase Assay + AKT2 Kinase Enzyme System

 Components

  • AKT2 Kinase Enzyme System

    V38611 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V9041 £ 499.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V3861, V3862, V9041 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V9041 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V9041 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V9041 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V9041 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V9041 U.S. Pat. No. 8,183,007 and other patents pending.

V9041 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V9041 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.